HomeVSTM • NASDAQ
add
Verastem Inc
Previous close
$7.50
Day range
$7.46 - $8.12
Year range
$2.10 - $13.52
Market cap
386.18M USD
Avg Volume
877.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 0.00 | — |
Operating expense | 31.59M | 1.45% |
Net income | -64.55M | -135.86% |
Net profit margin | — | — |
Earnings per share | -0.60 | 45.45% |
EBITDA | -31.58M | -1.44% |
Effective tax rate | -0.29% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.82M | -35.23% |
Total assets | 101.54M | -32.18% |
Total liabilities | 130.43M | 83.23% |
Total equity | -28.89M | — |
Shares outstanding | 51.49M | — |
Price to book | -11.54 | — |
Return on assets | -69.30% | — |
Return on capital | -181.53% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -64.55M | -135.86% |
Cash from operations | -25.10M | 15.44% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 742.00K | 266.37% |
Net change in cash | -24.36M | -37.68% |
Free cash flow | -43.70M | -228.15% |
About
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia
Founded
2010
Headquarters
Website
Employees
78
